Background illustration for clinical trials search

Paid Clinical Trials Omaha

Discover 602 paid clinical trials in Omaha, Nebraska. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

for
Multiple Myeloma
Location: Omaha NE, Waukee IA, Iowa City IA, Rochester MN,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT07518186

Phase3, Recruiting

A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Omaha NE, Evanston IL, Louisville KY, Nashville TN,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06769698

Phase2, Recruiting

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: Omaha NE, Overland Park KS, Iowa City IA, Rochester MN,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer

for
Breast Neoplasms
Location: Omaha NE, Grand Island NE, Kansas City MO,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07173751

Phase3, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Omaha NE, Kansas City KS, Iowa City IA, St Louis MO,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer

for
HER2-positive Breast Cancer, Breast Cancer
Location: Omaha NE, Lincoln NE, Ames IA, Madison WI, Denver CO,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07102381

Phase2, Recruiting

Study of [177Lu]Lu-DWJ155 and [68Ga]Ga-DWJ155 in Patients With Solid Tumors

for
Breast Cancer, Non-small Cell Lung Cancer (NSCLC),
Location: Omaha NE, Montreal
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07660055

Phase1, Recruiting

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

for
Metastatic Non-small Cell Lung Cancer With MTAP Deletion
Location: Omaha NE, Rochester MN, Springdale AR, Lexington KY,
Sponsor: Bristol-Myers Squibb

Sex: All

Age: 18+

Code: NCT07063745

Phase2, Phase3, Recruiting

A Study of Tacabrutideg (BGB-16673) Compared to Investigator's Choice in Participants With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Previously Exposed to Both Bruton Tyrosine Kinase (BTK) and B-cell Leukemia/Lymphoma 2 Protein (BCL2) Inhibitors

for
CLL, Chronic Lymphocytic Leukemia
Location: Omaha NE, Minneapolis MN, Springfield MO,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06846671

Phase3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Omaha NE, Kansas City KS, St Louis MO, Milwaukee WI,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase2, Phase3, Recruiting

Study to Evaluate the Safety, Tolerability & Efficacy of TNG462 in Combination in PDAC & NSCLC Patients

for
PDAC, PDAC - Pancreatic Ductal Adenocarcinoma, NSCLC,
Location: Omaha NE, Iowa City IA, Rochester MN, Chicago IL,
Sponsor: Tango Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06922591

Phase1, Phase2, Recruiting

A Phase 1 Study of the Safety and Tolerability of CTX-10726

for
Gastroesophageal Cancer (GC), Hepatocellular Carcinoma (HCC),
Location: Omaha NE, Nashville TN, Pittsburgh PA, Greenville SC,
Sponsor: Compass Therapeutics

Sex: All

Age: 18+

Code: NCT07419841

Phase1, Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

for
Metastatic Castration Resistant Prostate Cancer (mCRPC),
Location: Omaha NE, Oklahoma City OK, Irving TX, Nashville TN,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT03460977

Phase1, Recruiting

The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies

for
Lymphoid Malignancies
Location: Omaha NE, Chicago IL, Memphis TN, Louisville KY,
Sponsor: AVM Biotechnology Inc

Sex: All

Age: 12 - 70+

Code: NCT04329728

Phase1, Phase2, Recruiting

Safely Optimizing Body Weight With Mifomelatide (TCMCB07) in Patients With Newly Diagnosed Colorectal Cancer (CRC) or Pancreatic Ductal Adenocarcinoma (PDAC) Undergoing Chemotherapy

for
Cancer Weight Loss
Location: Omaha NE, Lincoln NE, Wichita KS, Oklahoma City OK,
Sponsor: Endevica Bio

Sex: All

Age: 18+

Code: NCT06937177

Phase2, Recruiting

Lead-212 PSV359 Therapy for Patients With Solid Tumors

for
Pancreatic Ductal Adenocarcinoma, Gastric Cancer,
Location: Omaha NE, Kansas City KS, Rochester MN, St Louis MO,
Sponsor: Perspective Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06710756

Phase1, Phase2, Recruiting

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

for
Gastroesophageal-junction Cancer, Monoclonal Antibody,
Location: Omaha NE, Des Moines IA, Iowa City IA, St Louis MO,
Sponsor: Shanghai Henlius Biotech

Sex: All

Age: 18+

Code: NCT06532006

Phase3, Recruiting

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

for
Early Breast Cancer
Location: Omaha NE, Sioux Falls SD, Kansas City MO,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 70+

Code: NCT05827081

Phase3, Recruiting

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

for
Breast Cancer, Metastatic Breast Cancer, Breast Neoplasm,
Location: Omaha NE, Kansas City KS, Rochester MN, Springfield IL,
Sponsor: BriaCell Therapeutics Corporation

Sex: All

Age: 18+

Code: NCT06072612

Phase3, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Omaha NE, Yankton SD, Sioux Falls SD, Mitchell SD,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase3, Recruiting